Bibliography

Found 1068 results

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C

Alakkas A, Ellis R, Watson W, Heaton R, Letendre S, Collier A, Marra C, Clifford D, Gelmen B, Sacktor NC, et al. Cerebral volumetric and metabolic abnormalities in HIV associated neurocognitive disorders (HAND). 2017 .

Soontornniyomkij V, Moore D, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, et al. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS [Internet]. 2012 ;26(18):2327-2335. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23018443

Goodkin K, Vitiello B, Lyman WD, Asthana D, Atkinson JH, Heseltine PNR, Molina R, Zheng W, Khamis I, Wilkie FL, et al. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment. Journal of NeuroVirology [Internet]. 2006 ;12(3):178-89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877299

Mehta SR, Pérez-Santiago J, Hulgan T, Day TRC, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, et al. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J Neuroinflammation. 2017 ;14(1):72.

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR, Rosario-Cookson D, et al. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. Mol Neurobiol. 2019 ;56(5):3808-3818.

Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre SL, Ellis RJ, Bush WS, Samuels DC, et al. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. Fluids Barriers CNS. 2017 ;14(1):11.

Guha D, Mukerji SS, Chettimada S, Misra V, Lorenz DR, Morgello S, Gabuzda D. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy. AIDS. 2019 ;33(4):615-625.

Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS [Internet]. 2014 ;28(11):1579-1591. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24752083

Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS. 2014 ;28(11):1579-91.

Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, Nelson S, Velasco-Gonzalez C, Zabaleta J, Peruzzi F. Cerebrospinal Fluid miRNA Profile in HIV-Encephalitis. Journal of Cellular Physiology [Internet]. 2013 ;228(5):1070-1075. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23042033

Rozek W, Ricardo-Dukelow M, Holloway S, Gendelman HE, Wojna V, Meléndez LM, Ciborowski P. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. Journal of Proteome Research [Internet]. 2007 ;6:4189-99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17929958

Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.

Shapshak P. Challenges in Health Research Funding: an opinion. Bioinformation. 2015 ;11(2):55-6.

Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS (London, England) [Internet]. 2000 ;14:69-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10714569

Adiga R, Ozdemir AY, Carides A, Wasilewski M, Yen W, Chitturi P, Ellis RJ, Langford D. Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count. Journal of NeuroVirology [Internet]. 2014 ;20(4):371-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24817145

Adiga R, Ozdemir AY, Carides A, Wasilewski M, Yen W, Chitturi P, Ellis R, Langford D. Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count. J Neurovirol. 2014 ;20(4):371-9.

Langford D, Letendre S, Larrea GJ, Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology (Zurich, Switzerland) [Internet]. 2003 ;13(2):195-210. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12744473

Robinson-Papp J, Gensler G, Navis A, Sherman S, Ellis RJ, Gelman BB, Kolson DL, Letendre SL, Singer EJ, Valdes-Sueiras M, et al. Characteristics of Motor Dysfunction in Longstanding Human Immunodeficiency Virus. Clin Infect Dis [Internet]. 2020 ;71(6):1532-1538. Available from: https://pubmed.ncbi.nlm.nih.gov/31587032/

Rivera-Mindt M, Byrd D, Ryan EL, Robbins RN, Monzones J, Arentoft A, Germano KK, Morgello S, Henniger DE. Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals. Cultural Diversity & Ethnic Minority Psychology [Internet]. 2008 ;14:315-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18954167

Wüthrich C, Kesari S, Kim W-K, Williams KC, Gelman R, Elmeric D, De Girolami U, Joseph J, Hedley-Whyte T, Koralnik IJ. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. Journal of Neurovirology [Internet]. 2006 ;12(2):116-28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798673

Biswas B, Spitznagel E, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB. Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort. J HIV AIDS Soc Serv. 2014 ;13(1):8-25.

Mocchetti I, Bachis A, Masliah E. Chemokine receptors and neurotrophic factors: potential therapy against aids dementia?. Journal of Neuroscience Research [Internet]. 2008 ;86:243-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17847079

Sakabumi DZ, Moore RC, Tang B, Delaney PA, Keltner JR, Ellis RJ. Chronic Distal Sensory Polyneuropathy Is a Major Contributor to Balance Disturbances in Persons Living With HIV. J Acquir Immune Defic Syndr. 2019 ;80(5):568-573.

Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the national institutes of health mu. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society [Internet]. 2013 ;19(6):619-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23512786

Saloner R, Paolillo EW, Heaton RK, Grelotti DJ, Stein MB, Miller AH, J Atkinson H, Letendre SL, Ellis RJ, Grant I, et al. Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. J Neurovirol. 2021 ;27(1):160-167.

Pages